How a dramatic decline in hepatitis C infections in England brings us close to elimination
- UKHSA’s latest data reveals a 56.7% decline in chronic hepatitis C virus (HCV) infections across England.
- With cases dropping from an estimated 129,400 in 2015 to 55,900 in 2023, significant strides have been made towards eliminating HCV in England.
UK is no better prepared: key takeaways from Covid inquiry’s test, trace and isolation module
- The Covid inquiry has spent the past three weeks on the UK’s attempts to control the pandemic through test, trace and isolation.
- This article looks at the key findings from the module and experts’ recommendations for future pandemic preparedness.
- A new study, led by experts at the University of Nottingham, has found that young people suffering from certain types of cancer, such as bone tumours, are experiencing lengthy times to diagnosis.
- The Childhood Cancer Diagnosis Study, which is published in the Lancet Regional Health – Europe, was funded by the National Institute for Health and Care Research (NIHR).
- Childhood cancer has been declared a global disease burden, with early diagnosis a priority. The aim of this study was to help researchers understand the journey that children and young people experience from the start of their symptoms until they receive their cancer diagnosis.
Fresh UK-EU collaboration on AI to unlock new avenues for innovation and research
- Healthcare treatments, clean energy technologies and advanced breakthroughs that could transform lives across the UK are within reach, as the government backs plans for a new AI collaboration with Europe.
- From today, public research organisations can apply to host the UK’s AI Factory Antenna – a facility that, if approved, would link British research expertise to its advanced supercomputers across Europe.
Sir Chris Hoy on the revolutionary £42m prostate cancer trial that aims to ‘save countless lives’
- Sir Chris Hoy has thrown his support behind a new cancer detection trial, saying he hopes it will “revolutionise” how men are screened and “save countless lives”.
- The 49-year-old, who is battling prostate cancer and has been told by doctors he has just two to four years to live, has given his backing to the new Prostate Cancer UK trial called TRANSFORM.
- The £42 million initiative, billed as the biggest prostate cancer screening trial in 20 years, has been developed with the backing of the NHS.
Countries agree to update action plan to reduce deaths from antimicrobial resistance
- The Seventy-eighth World Health Assembly approved a decision to update the Global action plan (GAP) on antimicrobial resistance (AMR), for discussion at next year’s World Health Assembly (WHA79) in 2026.
- An estimated 4.71 million deaths were associated with bacterial AMR as of 2021, according to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD).
- The GAP update will offer a practical framework for the next 10 years to achieve the targets and commitments included in the political declaration of the United Nations General Assembly High-Level Meeting on AMR in 2024 – including a 10% reduction in global deaths associated with bacterial AMR by 2030.
